Back to search
Central Line-associated Bloodstream Infection (CLABSI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line-associated Bloodstream Infection (CLABSI) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line-associated Bloodstream Infection (CLABSI) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult partici…
In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications,…
In recent years, with the rapid advancement of medical technology and the rapid development of critical care medicine, the use of various central venous cathete…
The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on…
* Review key history and clinical examination findings of cases with CLABSI. * Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert a…
The aim of this multicenter randomized clinical trial is to compare the tunneling technique of PICC insertion with the non-tunneled insertion technique in the i…
For newborns admitted to Neonatal Intensive Care Units (NICUs), one of the main risk factors for late-onset sepsis is the presence of a central venous catheter…
The goal of this clinical trial is to compare a chlorhexidine antimicrobial barrier cap in patients requiring hemodialysis treatment to the standard hemodialysi…